Yoshimura, A., Naka, T. & Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454–465 (2007).
Rabinovich, G. A., van Kooyk, Y. & Cobb, B. A. Glycobiology of immune responses. Ann. N. Y. Acad. Sci. 1253, 1–15 (2012).
Cummings, R. D. The repertoire of glycan determinants in the human glycome. Mol. Biosyst. 5, 1087–1104 (2009).
Levi, G., Tarrab-Hazdai, R. & Teichberg, V. I. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur. J. Immunol. 13, 500–507 (1983).
Cummings, R. D. et al. in Essentials of Glycobiology (ed. Varki, A.) 4th edn., 491–503 (Cold Spring Harbor Laboratory Press, 2022).
Arthur, C. M., Baruffi, M. D., Cummings, R. D. & Stowell, S. R. Evolving mechanistic insights into galectin functions. Methods Mol. Biol. 1207, 1–35 (2015).
de Waard, A., Hickman, S. & Kornfeld, S. Isolation and properties of β-galactoside binding lectins of calf heart and lung. J. Biol. Chem. 251, 7581–7587 (1976).
Dias-Baruffi, M. et al. Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle. Glycobiology 20, 507–520 (2010).
Chen, X. et al. Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine. Allergy 66, 1038–1046 (2011).
Wada, J., Ota, K., Kumar, A., Wallner, E. I. & Kanwar, Y. S. Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside binding lectin. J. Clin. Invest. 99, 2452–2461 (1997).
Imaizumi, T. et al. Interferon-γ stimulates the expression of galectin-9 in cultured human endothelial cells. J. Leukoc. Biol. 72, 486–491 (2002).
Yang, R. Y. et al. Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice. Proc. Natl Acad. Sci. USA 108, 18696–18701 (2011).
Kamili, N. A. et al. Key regulators of galectin–glycan interactions. Proteomics 16, 3111–3125 (2016).
Johannes, L., Jacob, R. & Leffler, H. Galectins at a glance. J. Cell. Sci. 131, jcs208884 (2018).
Mendez-Huergo, S. P., Blidner, A. G. & Rabinovich, G. A. Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis. Curr. Opin. Immunol. 45, 8–15 (2017).
Ruvolo, P. P. Galectin 3 as a guardian of the tumor microenvironment. Biochim. Biophys. Acta 1863, 427–437 (2016).
Elola, M. T. et al. Galectins: multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment. Cell Immunol. 333, 34–45 (2018).
Cardoso, A. C., Andrade, L. N., Bustos, S. O. & Chammas, R. Galectin-3 determines tumor cell adaptive strategies in stressed tumor microenvironments. Front. Oncol. 6, 127 (2016).
Girotti, M. R., Salatino, M., Dalotto-Moreno, T. & Rabinovich, G. A. Sweetening the hallmarks of cancer: galectins as multifunctional mediators of tumor progression. J. Exp. Med. 217, e20182041 (2020).
Hirabayashi, J. et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 1572, 232–254 (2002).
Stowell, S. R. et al. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 283, 10109–10123 (2008).
Carlsson, S. et al. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 17, 663–676 (2007).
Cooper, D. N. & Barondes, S. H. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J. Cell Biol. 110, 1681–1691 (1990).
Cho, M. & Cummings, R. D. Galectin-1, a β-galactoside-binding lectin in Chinese hamster ovary cells. II. Localization and biosynthesis. J. Biol. Chem. 270, 5207–5212 (1995).
Cerri, D. G. et al. Degeneration of dystrophic or injured skeletal muscles induces high expression of galectin-1. Glycobiology 18, 842–850 (2008).
Banfer, S. et al. Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion. Proc. Natl Acad. Sci. USA 115, E4396–E4405 (2018).
Stowell, S. R. et al. Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation. J. Biol. Chem. 284, 4989–4999 (2009).
Hirabayashi, J. & Kasai, K. Effect of amino acid substitution by sited-directed mutagenesis on the carbohydrate recognition and stability of human 14-kDa β-galactoside-binding lectin. J. Biol. Chem. 266, 23648–23653 (1991).
Teichberg, V. I., Silman, I., Beitsch, D. D. & Resheff, G. A β-d-galactoside binding protein from electric organ tissue of Electrophorus electricus. Proc. Natl Acad. Sci. USA 72, 1383–1387 (1975).
Ochieng, J. et al. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 33, 14109–14114 (1994).
Robinson, B. S. et al. The sweet-side of leukocytes: galectins as master regulators of neutrophil function. Front. Immunol. 10, 1762 (2019).
Thiemann, S. & Baum, L. G. Galectins and immune responses — just how do they do those things they do? Annu. Rev. Immunol. 34, 243–264 (2016).
Pereira, M. S. et al. Glycans as key checkpoints of T cell activity and function. Front. Immunol. 9, 2754 (2018).
Gilson, R. C., Gunasinghe, S. D., Johannes, L. & Gaus, K. Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling. Prog. Lipid Res. 76, 101010 (2019).
Stowell, S. R. et al. Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology 14, 157–167 (2004).
Demetriou, M., Granovsky, M., Quaggin, S. & Dennis, J. W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733–739 (2001).
Smith, L. K. et al. Interleukin-10 directly inhibits CD8+ T cell function by enhancing N-glycan branching to decrease antigen sensitivity. Immunity 48, 299–312 e295 (2018).
Chen, H. Y. et al. Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse. Proc. Natl Acad. Sci. USA 106, 14496–14501 (2009).
Wang, S. F. et al. Galectin-3 promotes HIV-1 budding via association with Alix and Gag p6. Glycobiology 24, 1022–1035 (2014).
Kaur, M. et al. Galectin-3 regulates γ-herpesvirus specific CD8 T cell immunity. iScience 9, 101–119 (2018).
Chen, H. Y. et al. Intracellular galectin-9 enhances proximal TCR signaling and potentiates autoimmune diseases. J. Immunol. 204, 1158–1172 (2020).
Liang, C. C. et al. Galectin-9 is critical for mucosal adaptive immunity through the T helper 17–IgA axis. Am. J. Pathol. 188, 1225–1235 (2018).
Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998).
Perillo, N. L., Pace, K. E., Seilhamer, J. J. & Baum, L. G. Apoptosis of T cells mediated by galectin-1. Nature 378, 736–739 (1995).
Toscano, M. A. et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8, 825–834 (2007).
Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6, 1245–1252 (2005).
Pardo, E. et al. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis. PLoS ONE 12, e0177472 (2017).
留言 (0)